Biological Products, (No Diagnostic Substances)·MELBOURNE, VICTORIA, C3
All Filings(550 total)
TypeDateAccessionPeriodSize
6-K
Feb 27, 2026
0001345099-26-0000296-K
Feb 27, 2026
6.1 MB
6-K
Feb 27, 2026
0001345099-26-0000276-K
Dec 31, 2025
11.4 MB
6-K
Feb 23, 2026
0001345099-26-0000246-K
Feb 23, 2026
379.7 KB
6-K
Feb 12, 2026
0001345099-26-0000226-K
Feb 12, 2026
809.6 KB
6-K
Jan 29, 2026
0001345099-26-0000206-K
Jan 29, 2026
2.3 MB
6-K
Jan 28, 2026
0001345099-26-0000186-K
Jan 28, 2026
889.2 KB
6-K
Jan 21, 2026
0001345099-26-0000166-K
Jan 19, 2026
1.0 MB
6-K
Jan 16, 2026
0001345099-26-0000146-K
Jan 16, 2026
1.1 MB
EFFECT
Jan 14, 2026
9999999995-26-000172
—
1.7 KB
424B3
Jan 14, 2026
0001213900-26-004248PROSPECTUS
—
320.0 KB
6-K
Jan 14, 2026
0001345099-26-0000126-K
Jan 14, 2026
1.8 MB
6-K
Jan 13, 2026
0001345099-26-0000096-K
Jan 12, 2026
368.5 KB
6-K
Jan 9, 2026
0001345099-26-0000076-K
Jan 9, 2026
779.0 KB
6-K
Jan 7, 2026
0001345099-26-0000056-K
Jan 7, 2026
920.9 KB
6-K
Jan 2, 2026
0001345099-26-0000026-K
Jan 2, 2026
771.0 KB
F-3ASR
Dec 31, 2025
0001213900-25-126785REGISTRATION STATEMENT
—
527.3 KB
F-3
Dec 30, 2025
0001213900-25-126633REGISTRATION STATEMENT
—
545.8 KB
6-K
Dec 30, 2025
0001345099-25-0001136-K
Dec 30, 2025
1.5 MB
6-K
Dec 29, 2025
0001345099-25-0001116-K
Dec 24, 2025
527.5 KB
6-K
Dec 18, 2025
0001345099-25-0001096-K
Dec 17, 2025
758.6 KB
6-K
Dec 12, 2025
0001345099-25-0001076-K
Dec 12, 2025
771.0 KB
6-K
Dec 4, 2025
0001345099-25-0001056-K
Dec 4, 2025
726.6 KB
6-K
Nov 26, 2025
0001345099-25-0001036-K
Nov 25, 2025
638.9 KB
6-K
Nov 25, 2025
0001345099-25-0001016-K
Nov 25, 2025
5.1 MB
6-K
Nov 24, 2025
0001345099-25-0000996-K
Nov 21, 2025
1.3 MB
25 filings shown
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain.